News

The payment was granted for the identification of a number of lead series for a priority target of this collaboration. Further projects within the multi-target three year collaboration

In a UK National Cancer Research Institute multi-center study of older patients with acute myeloid leukemia (AML) who were unsuitable for intensive chemotherapy, the overall response for clofarabine

The collaboration combines the intellectual property and biological capabilities of both companies to target proteins and genes that are involved in cell proliferation and differentiation. Under the collaboration,

This is the first study comparing acetaminophen against ibuprofen in alleviating the pain associated with ankle sprains. Conducted as a multicenter, randomized, double-blind trial, the study followed 260

Tovaxin is a trivalent formulation of attenuated myelin-peptide reactive T cells (MRTCs), which are derived from peripheral blood and produced ex vivo as myelin basic protein (MBP), proteolipid

This technology is expected to offer a lower-cost manufacturing alternative for the production of many protein drugs, with additional potential advantages in the quality of the products. The

Clinical data from a phase Ib combination trial, in which KOS-953 was administered with bortezomib (Millennium’s Velcade), also showed signs of anti-myeloma activity in bortezomib-naive and -refractory patients.

These findings are significant as very few products have been able to show nerve repair in models of spinal cord injury and no products to date have achieved

Not only was the area affected by stroke minimized, the treated animals had significantly less neurological defects as assessed by several behavioral tests. In theory, this could indicate